Ignite Creation Date:
2025-12-24 @ 12:42 PM
Ignite Modification Date:
2026-01-15 @ 12:16 PM
Study NCT ID:
NCT00536861
Status:
COMPLETED
Last Update Posted:
2008-05-29
First Post:
2007-09-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer
Sponsor:
Amsterdam UMC, location VUmc
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
VUMC 2005/177
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Professor S Senan
Old Organization:
VU Medical Center